NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE was reported 203 times

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VITREOUS ABSCESS 1 0.0909
1 CORNEAL ENDOTHELIAL CELL LOSS 2 0.0294
2 VITAMIN B1 INCREASED 1 0.0213
3 CHOROIDAL DYSTROPHY 1 0.0208
4 INFUSION SITE DRYNESS 1 0.0185
5 EXPOSURE VIA MUCOSA 1 0.0167
6 RUBELLA 1 0.0088
7 VITREOUS ADHESIONS 1 0.0087
8 ANTERIOR CHAMBER FIBRIN 1 0.0078
9 KERATITIS FUNGAL 1 0.0048
10 EYELASH DISCOLOURATION 1 0.0046
11 CONJUNCTIVITIS VIRAL 1 0.0038
12 SCLERAL DISORDER 1 0.0037
13 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
14 PHARYNGEAL HYPOAESTHESIA 3 0.0032
15 FOREIGN BODY IN EYE 3 0.0031
16 KERATIC PRECIPITATES 1 0.0021
17 INFUSION SITE ABSCESS 1 0.0020
18 APPLICATION SITE INFECTION 1 0.0020
19 IRIS ADHESIONS 1 0.0019
20 SUPERFICIAL INJURY OF EYE 2 0.0018
21 OCULAR TOXICITY 2 0.0018
22 CORNEAL EPITHELIUM DEFECT 1 0.0017
23 OTORRHOEA 3 0.0017
24 NASAL CRUSTING 1 0.0015
25 EAR HAEMORRHAGE 3 0.0015
26 CORNEAL ABRASION 2 0.0015
27 EAR SWELLING 3 0.0014
28 PRODUCT DROPPER ISSUE 1 0.0013
29 BREAST OPERATION 1 0.0012
30 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
31 CYSTOID MACULAR OEDEMA 2 0.0011
32 EYELID RASH 1 0.0010
33 MASTOIDITIS 1 0.0010
34 STOMA COMPLICATION 1 0.0010
35 CONJUNCTIVAL OEDEMA 1 0.0010
36 PNEUMONIA STREPTOCOCCAL 1 0.0009
37 HALO VISION 1 0.0009
38 EYELID DISORDER 2 0.0009
39 INSTILLATION SITE IRRITATION 1 0.0008
40 EYELID SKIN DRYNESS 1 0.0008
41 EYELID IRRITATION 2 0.0008
42 HERPES OPHTHALMIC 1 0.0008
43 PRODUCT CONTAINER ISSUE 6 0.0007
44 EYE IRRITATION 40 0.0007
45 HORDEOLUM 3 0.0007
46 EYELID MARGIN CRUSTING 2 0.0007
47 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
48 EYE ALLERGY 1 0.0006
49 NIGHT BLINDNESS 1 0.0006
50 RETINAL THICKENING 1 0.0006
51 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
52 VERTIGO POSITIONAL 1 0.0006
53 INFUSION SITE DISCHARGE 1 0.0006
54 ERYTHEMA OF EYELID 3 0.0006
55 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
56 VITRITIS 1 0.0005
57 OCULAR HYPERTENSION 1 0.0005
58 OCULAR HYPERAEMIA 23 0.0005
59 ABNORMAL SENSATION IN EYE 2 0.0005
60 CORNEAL OEDEMA 1 0.0004
61 INFUSION SITE INFECTION 1 0.0004
62 PRODUCT PACKAGING CONFUSION 1 0.0004
63 INJECTION SITE ABSCESS 1 0.0004
64 EAR DISCOMFORT 4 0.0004
65 EYE PAIN 21 0.0004
66 BRUXISM 2 0.0004
67 RESPIRATORY SYMPTOM 1 0.0004
68 EYELID OEDEMA 4 0.0003
69 FIBROSIS 1 0.0003
70 SWELLING OF EYELID 2 0.0003
71 INFUSION SITE PRURITUS 1 0.0003
72 FOREIGN BODY SENSATION IN EYES 2 0.0003
73 SKIN EROSION 1 0.0003
74 INFUSION SITE HAEMORRHAGE 1 0.0003
75 SKIN INJURY 1 0.0003
76 EYE SWELLING 11 0.0003
77 GRANULOMA 1 0.0003
78 EYE DISCHARGE 3 0.0003
79 LOGORRHOEA 1 0.0003
80 HYPERACUSIS 1 0.0003
81 OCULAR DISCOMFORT 3 0.0003
82 EYE INFECTION 3 0.0003
83 BLEPHARITIS 1 0.0002
84 EYE PRURITUS 8 0.0002
85 PURULENT DISCHARGE 1 0.0002
86 ADVERSE REACTION 3 0.0002
87 PRODUCT TASTE ABNORMAL 3 0.0002
88 HAEMOGLOBIN INCREASED 1 0.0002
89 EAR PAIN 4 0.0002
90 HYPERVOLAEMIA 1 0.0002
91 KLEBSIELLA INFECTION 1 0.0002
92 WEIGHT LOSS POOR 1 0.0002
93 ENDOCARDITIS 1 0.0002
94 DERMATITIS 4 0.0002
95 VISION BLURRED 26 0.0002
96 ANORECTAL DISCOMFORT 1 0.0002
97 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
98 DEAFNESS UNILATERAL 1 0.0002
99 PRODUCT LEAKAGE 1 0.0002
100 SCAB 2 0.0002
101 NEUROLOGICAL SYMPTOM 1 0.0002
102 NASAL DRYNESS 1 0.0002
103 PHOTOPHOBIA 3 0.0002
104 INFUSION SITE SWELLING 1 0.0002
105 INTRAOCULAR PRESSURE INCREASED 2 0.0002
106 INFUSION SITE PAIN 2 0.0002
107 POSTOPERATIVE WOUND INFECTION 1 0.0001
108 WRONG PRODUCT ADMINISTERED 1 0.0001
109 EYE MOVEMENT DISORDER 1 0.0001
110 BLINDNESS TRANSIENT 1 0.0001
111 FEELING DRUNK 1 0.0001
112 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
113 FRUSTRATION TOLERANCE DECREASED 1 0.0001
114 ABNORMAL FAECES 1 0.0001
115 INFUSION SITE ERYTHEMA 1 0.0001
116 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
117 WRONG DRUG ADMINISTERED 1 0.0001
118 NERVE COMPRESSION 1 0.0001
119 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
120 CONJUNCTIVITIS 2 0.0001
121 ARTERIOSCLEROSIS 1 0.0001
122 PRODUCT PACKAGING ISSUE 1 0.0001
123 EYE INFLAMMATION 1 0.0001
124 LACRIMATION INCREASED 3 0.0001
125 INITIAL INSOMNIA 1 0.0001
126 SKIN LACERATION 1 0.0001
127 PRODUCT DISPENSING ERROR 2 0.0001
128 PULMONARY THROMBOSIS 1 0.0001
129 GASTROINTESTINAL PAIN 1 0.0001
130 VISUAL IMPAIRMENT 11 0.0001
131 NO THERAPEUTIC RESPONSE 1 0.0001
132 SPINAL OPERATION 1 0.0001
133 GENERALISED OEDEMA 1 0.0001
134 DRY EYE 4 0.0001
135 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
136 EYE HAEMORRHAGE 1 0.0001
137 MASS 1 0.0001
138 HYPERSENSITIVITY 13 0.0001
139 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
140 SKIN HAEMORRHAGE 1 0.0001
141 THROAT IRRITATION 3 0.0001
142 DRUG DISPENSING ERROR 1 0.0001
143 PHARYNGEAL OEDEMA 1 0.0001
144 THERAPY PARTIAL RESPONDER 1 0.0001
145 PRODUCT USE COMPLAINT 1 0.0001
146 RESPIRATORY TRACT CONGESTION 1 0.0001
147 EYE DISORDER 2 0.0001
148 HEMIPARESIS 1 0.0001
149 PRODUCT QUALITY ISSUE 8 0.0001
150 MUSCULOSKELETAL DISCOMFORT 1 0.0001
151 THIRST 1 0.0001
152 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
153 POST PROCEDURAL COMPLICATION 1 0.0001
154 PULMONARY HYPERTENSION 1 0.0000
155 EATING DISORDER 1 0.0000
156 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
157 SWELLING FACE 3 0.0000
158 CONDITION AGGRAVATED 14 0.0000
159 PRODUCT AVAILABILITY ISSUE 1 0.0000
160 SKIN DISCOLOURATION 2 0.0000
161 PERICARDIAL EFFUSION 1 0.0000
162 OROPHARYNGEAL PAIN 4 0.0000
163 EXPOSURE VIA SKIN CONTACT 1 0.0000
164 DIPLOPIA 1 0.0000
165 DEAFNESS 1 0.0000
166 EAR INFECTION 1 0.0000
167 LIMB INJURY 1 0.0000
168 ABNORMAL DREAMS 1 0.0000
169 LIVER FUNCTION TEST ABNORMAL 1 0.0000
170 BONE PAIN 2 0.0000
171 VERTIGO 2 0.0000
172 HIP FRACTURE 1 0.0000
173 STAPHYLOCOCCAL INFECTION 1 0.0000
174 VISUAL ACUITY REDUCED 1 0.0000
175 CHEST DISCOMFORT 3 0.0000
176 DEVICE USE ERROR 1 0.0000
177 BURNING SENSATION 2 0.0000
178 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
179 DYSURIA 1 0.0000
180 INJECTION SITE MASS 1 0.0000
181 HOT FLUSH 2 0.0000
182 INJECTION SITE HAEMORRHAGE 2 0.0000
183 DRY MOUTH 2 0.0000
184 BLINDNESS 1 0.0000
185 POLLAKIURIA 1 0.0000
186 PRODUCT DOSE OMISSION ISSUE 7 0.0000
187 HYPOACUSIS 1 0.0000
188 DRY SKIN 3 0.0000
189 THERAPY NON-RESPONDER 1 0.0000
190 SKIN IRRITATION 1 0.0000
191 PRODUCT USE ISSUE 4 0.0000
192 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
193 PRURITUS 8 0.0000
194 INTERSTITIAL LUNG DISEASE 1 0.0000
195 FLUID RETENTION 1 0.0000
196 PERIPHERAL SWELLING 3 0.0000
197 DERMATITIS ATOPIC 1 0.0000
198 RASH PRURITIC 1 0.0000
199 OEDEMA 1 0.0000
200 RASH 8 0.0000
201 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
202 INCORRECT DOSE ADMINISTERED 4 0.0000
203 LETHARGY 1 0.0000
204 SURGERY 1 0.0000
205 IRRITABILITY 1 0.0000
206 DISCOMFORT 1 0.0000
207 NEOPLASM MALIGNANT 1 0.0000
208 OFF LABEL USE 13 0.0000
209 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
210 ERYTHEMA 3 0.0000
211 COUGH 4 0.0000
212 THERAPY INTERRUPTED 1 0.0000
213 SKIN BURNING SENSATION 1 0.0000
214 EPISTAXIS 1 0.0000
215 HYPOAESTHESIA 2 0.0000
216 UNEVALUABLE EVENT 1 0.0000
217 ACNE 1 0.0000
218 DIABETES MELLITUS 1 0.0000
219 INJECTION SITE SWELLING 1 0.0000
220 DECREASED APPETITE 3 0.0000
221 ARTHRITIS 1 0.0000
222 INJECTION SITE BRUISING 1 0.0000
223 FEELING ABNORMAL 3 0.0000
224 CARDIAC ARREST 1 0.0000
225 TREATMENT FAILURE 1 0.0000
226 BALANCE DISORDER 1 0.0000
227 PRODUCT STORAGE ERROR 1 0.0000
228 INTENTIONAL PRODUCT MISUSE 1 0.0000
229 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
230 COVID-19 2 0.0000
231 ADVERSE DRUG REACTION 1 0.0000
232 SUICIDAL IDEATION 1 0.0000
233 MUSCLE SPASMS 2 0.0000
234 NASOPHARYNGITIS 2 0.0000
235 MIGRAINE 1 0.0000
236 DRUG INTOLERANCE 1 0.0000
237 ATRIAL FIBRILLATION 1 0.0000
238 PAIN IN EXTREMITY 3 0.0000
239 HEART RATE INCREASED 1 0.0000
240 HAEMOGLOBIN DECREASED 1 0.0000
241 OVERDOSE 2 0.0000
242 INFLUENZA 1 0.0000
243 WEIGHT INCREASED 2 0.0000
244 MUSCULAR WEAKNESS 1 0.0000
245 VOMITING 4 0.0000
246 PAIN 5 0.0000
247 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
248 HYPERHIDROSIS 1 0.0000
249 DYSPNOEA 4 0.0000
250 MALAISE 3 0.0000
251 DRUG INEFFECTIVE 9 0.0000
252 INJECTION SITE PAIN 2 0.0000
253 HOSPITALISATION 1 0.0000
254 FATIGUE 5 0.0000
255 NAUSEA 5 0.0000
256 DRUG DEPENDENCE 1 0.0000
257 DIARRHOEA 4 0.0000
258 PNEUMONIA 2 0.0000
259 DIZZINESS 3 0.0000
260 URTICARIA 1 0.0000
261 ABDOMINAL DISCOMFORT 1 0.0000
262 MYALGIA 1 0.0000
263 MYOCARDIAL INFARCTION 1 0.0000
264 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
265 NO ADVERSE EVENT 1 0.0000
266 CHEST PAIN 1 0.0000
267 ASTHENIA 2 0.0000
268 GAIT DISTURBANCE 1 0.0000
269 HYPOTENSION 1 0.0000
270 SOMNOLENCE 1 0.0000
271 ABDOMINAL PAIN UPPER 1 0.0000
272 HYPERTENSION 1 0.0000
273 CONSTIPATION 1 0.0000
274 BACK PAIN 1 0.0000
275 ABDOMINAL PAIN 1 0.0000
276 WEIGHT DECREASED 1 0.0000
277 ANXIETY 1 0.0000
278 HEADACHE 2 0.0000
279 FALL 1 0.0000
280 ARTHRALGIA 1 0.0000
281 DEATH 2 0.0000